Dr. Hillary Danielle Johnson-Jahangir, MD

Dr. Johnson-Jahangir practices at Forefront Dermatology, S.C. in West Burlington, Iowa.

Dr. Johnson-Jahangir's NPI, 1710193644, was assigned on May 15, 2007. Dr. Johnson-Jahangir graduated from University of Washington School of Medicine in 2004. Dr. Johnson-Jahangir holds Iowa license MD-41815.

Dr. Johnson-Jahangir's primary practice is Forefront Dermatology, S.C., at 1225 S Gear Ave, West Burlington, IA 52655 in Des Moines County. The practice phone is (319) 294-4319.

Dr. Johnson-Jahangir's primary practice is Forefront Dermatology, S.C. in West Burlington, Iowa. The medical group on file is Forefront Dermatology. Dmand AI also links Dr. Johnson-Jahangir to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson-Jahangir practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Johnson-Jahangir's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Dr. Johnson-Jahangir's licenses on file in 2 states: Iowa and Illinois.

CMS data shows 1,606 Medicare services from Dr. Johnson-Jahangir across 24 procedure codes in 2024, for 637 Medicare patients. Medicare paid $448,213 for them. Every service was in an office.

CMS counts 637 Medicare patients who saw Dr. Johnson-Jahangir in 2024. The largest group is 65 to 74, with 305 patients. 69% of them have high blood pressure, and 69% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Johnson-Jahangir's median patient age at 68, with 54% women.

In 2024, Dr. Johnson-Jahangir wrote 52 Medicare Part D claims for 45 patients. 96% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $1,985 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Johnson-Jahangir for performance year 2024, reported as part of a group. Dr. Johnson-Jahangir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 301 procedures of melanoma (skin cancer) excision by Dr. Johnson-Jahangir, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Johnson-Jahangir, published from 2012 to 2020. 2016 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Mohs Surgery and Dermatofibrosarcoma. Dr. Johnson-Jahangir has published most often in Dermatol Surg. Dr. Johnson-Jahangir's most frequent co-authors are Pooja Chitgopeker, MD, Nkanyezi Ngwenyama Ferguson, MD and Rajiv I. Nijhawan, MD.

CMS Open Payments shows 45 general payments to Dr. Johnson-Jahangir from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $216.

Dr. Johnson-Jahangir graduated from University of Washington School of Medicine in 2004.